Panel discussion tackles effects of marijuana legalization on campus

A panel of cannabis use researchers says Canadians need to start preparing for the legalization of marijuana.

April 5, 2017

Experts Featured In This Story

Michael DeVillaer
Michael DeVillaer

Assistant Professor (Part-Time)

See Profile
James MacKillop
James MacKillop

Professor

See Profile

A panel of cannabis use researchers says Canadians need to start preparing for the legalization of marijuana.

The public forum, hosted March 28 at the McMaster Health Forum, featured the University of Guelph’s Franco Vaccarino, Mac drug policy researcher Michael DeVillaer, incoming Dean of Science Maureen MacDonald, addictions researcher James MacKillop and student Rodrigo Narro Perez.

Read: Forum says McMaster must prepare to deal with marijuana legalization

The group discussed what issues youth and large public institutions such as universities will face when marijuana is legalized in Canada.

The event was organized by McMaster’s Arrive and Thrive program, which gives students access to information and assistance that helps them identify unhealthy habits and learn how to modify them.

The McMaster Health Forum has produced a two-page summary, “Identifying the Impacts of Cannabis Legalization on Youth, and the Responses that can be Taken by Public Institutions,” which can be found here.

Marek Smieja smiles while standing outside on a bright day.

McMaster scientist Marek Smieja receives prestigious national award for infectious disease research 

The John G. FitzGerald Award recognizes Smieja for advancing the diagnosis and epidemiology of respiratory and gastrointestinal infections, including those caused by SARS-CoV-2, influenza, rhinovirus, and C. difficile.
Toronto skyline enveloped in yellowish smog.

Everyday air pollution linked to poorer brain function, study finds

New research suggests that fine particles from traffic, industry and wildfire smoke are linked to worse cognitive function.
Smiling Sheila Singh wearing a McMaster lab coat, looking over lab equipment.

New McMaster-made drug candidate shows promise as a brain cancer treatment 

The drug candidate can eliminate deadly and aggressive glioblastoma tumours, which typically resist standard treatments and often recur rapidly.